Improving the stability of thiol–maleimide bioconjugates via the formation of a thiazine structure
Journal of Peptide Science · 2023-10 · 29 (10)
DOI: 10.1002/psc.3495 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Peptide Science, online erschienen am 02.05.2023. Verfasst von Isaiah N Gober und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development Department, Bachem Americas, Inc., Torrance, CA, USA. Hauptthemen laut MEDLINE: Sulfhydryl Compounds, Cysteine. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Linker stability is critically important for the efficacy and safety of peptide and protein conjugates used for biological applications. One common conjugation strategy, thiol–maleimide coupling, generates a succinimidyl thioether linker with limited stability under physiological conditions. We have shown in previous work that when a peptide with an N‐terminal cysteine is conjugated to a maleimide reagent, a thiazine structure is formed via a chemical rearrangement. Our preliminary work indicated that the thiazine linker has favorable stability. Here, we report the evaluation of a thiazine linker as an alternative to the widely used succinimidyl thioether linker for thiol–maleimide bioconjugation. The stability of the thiazine conjugate in comparison to the thioether conjugate was assessed across a broad pH range. Additionally, the propensity for retro‐Michael reaction and cross‐reactivity with other thiols was evaluated by treating conjugates in the presence of glutathione. The studies indicated that the thiazine linker degrades markedly slower than the thioether conjugate. In addition, the thiazine linker is over 20 times less susceptible to glutathione adduct formation. The NMR study of the thiazine structure confirmed that the formation of the thiazine linker is a stereoselective process that yields a single diastereomer. In summary, we propose the use of the thiazine linker obtained by conjugation of maleimide‐containing reagents with peptides or proteins presenting an N‐terminal cysteine as a novel approach for bioconjugation. The advantages of this approach are the formation of a linker with a well‐defined stereochemical configuration, increased stability at physiological pH, and a strongly reduced propensity for thiol exchange.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research and Development Department, Bachem Americas, Inc., Torrance, CA, USA.
- CMC Development Group, Bachem Americas, Inc., Torrance, CA, USA.
ORCID-Profile: Isaiah N Gober, Rahul Sharan, Matteo Villain
Zitieren
APA
Gober, I. N., Sharan, R., & Villain, M. (2023). Improving the stability of thiol–maleimide bioconjugates via the formation of a thiazine structure. Journal of Peptide Science, 29(10). https://doi.org/10.1002/psc.3495
Vancouver
Gober IN, Sharan R, Villain M. Improving the stability of thiol–maleimide bioconjugates via the formation of a thiazine structure. Journal of Peptide Science. 2023;29(10). doi:10.1002/psc.3495
BibTeX
@article{Gober2023,
author = {Gober, Isaiah N and Sharan, Rahul and Villain, Matteo},
title = {Improving the stability of thiol–maleimide bioconjugates via the formation of a thiazine structure},
journal = {Journal of Peptide Science},
year = {2023},
volume = {29},
number = {10},
doi = {10.1002/psc.3495}
}
EUVIMED